PURPOSE: The incidence of anal cancer is increasing, particularly among HIV and men who have sex with men (MSM) groups. The vast majority of cases are associated with human papillomavirus (HPV), the most common sexually transmitted infection. Epidemiological studies have also documented low survival, which might be linked to lack of appropriate screening, access, and utilization of pertinent health care services. Our objective was to assess the relative survival (1 and 3 years) of anal cancer in Puerto Rico for men and women during the period from 2000-2007. METHODS: All histological types of cancer of anus, anal canal, and anorectum (ICD-O-3 codes C210-C218), except for sarcomas, were included. Relative survival was estimated with the use of life tables from the population of Puerto Rico. In addition, the excess survival was compared by age at diagnosis, histology, and stage (defined as local, regional, or distant), using the Poisson regression model. RESULTS: The overall 3-year relative survival in Puerto Rico was the same (53 %) for men and women. CONCLUSIONS: Our findings establish baseline survival data for anal cancer in Hispanics from Puerto Rico. Since now, the national guidelines for anal cancer screening and treatment are on their way to be determined; baseline information about survival will allow monitoring the efficacy that standardized screening programs may eventually have in increasing anal cancer survival in this population.
PURPOSE: The incidence of anal cancer is increasing, particularly among HIV and men who have sex with men (MSM) groups. The vast majority of cases are associated with human papillomavirus (HPV), the most common sexually transmitted infection. Epidemiological studies have also documented low survival, which might be linked to lack of appropriate screening, access, and utilization of pertinent health care services. Our objective was to assess the relative survival (1 and 3 years) of anal cancer in Puerto Rico for men and women during the period from 2000-2007. METHODS: All histological types of cancer of anus, anal canal, and anorectum (ICD-O-3 codes C210-C218), except for sarcomas, were included. Relative survival was estimated with the use of life tables from the population of Puerto Rico. In addition, the excess survival was compared by age at diagnosis, histology, and stage (defined as local, regional, or distant), using the Poisson regression model. RESULTS: The overall 3-year relative survival in Puerto Rico was the same (53 %) for men and women. CONCLUSIONS: Our findings establish baseline survival data for anal cancer in Hispanics from Puerto Rico. Since now, the national guidelines for anal cancer screening and treatment are on their way to be determined; baseline information about survival will allow monitoring the efficacy that standardized screening programs may eventually have in increasing anal cancer survival in this population.
Authors: Ana Patricia Ortiz; Marievelisse Soto-Salgado; Erick Suárez; María del Carmen Santos-Ortiz; Guillermo Tortolero-Luna; Cynthia M Pérez Journal: J Sex Med Date: 2011-06-15 Impact factor: 3.802
Authors: Vivian Colón-López; Carlos E Rodríguez-Díaz; Ana P Ortiz; Marivelisse Soto-Salgado; Erick Suárez; Cynthia M Pérez Journal: P R Health Sci J Date: 2011-06 Impact factor: 0.705
Authors: Joel M Palefsky; Anna R Giuliano; Stephen Goldstone; Edson D Moreira; Carlos Aranda; Heiko Jessen; Richard Hillman; Daron Ferris; Francois Coutlee; Mark H Stoler; J Brooke Marshall; David Radley; Scott Vuocolo; Richard M Haupt; Dalya Guris; Elizabeth I O Garner Journal: N Engl J Med Date: 2011-10-27 Impact factor: 91.245
Authors: Alexandra de Pokomandy; Danielle Rouleau; George Ghattas; Sylvie Vézina; Pierre Coté; John Macleod; Guy Allaire; Eduardo L Franco; François Coutlée Journal: J Infect Dis Date: 2009-04-01 Impact factor: 5.226
Authors: Joel M Palefsky; Elizabeth A Holly; Jimmy T Efirdc; Maria Da Costa; Naomi Jay; J Michael Berry; Teresa M Darragh Journal: AIDS Date: 2005-09-02 Impact factor: 4.177
Authors: Lisa G Johnson; Margaret M Madeleine; Laura M Newcomer; Stephen M Schwartz; Janet R Daling Journal: Cancer Date: 2004-07-15 Impact factor: 6.860
Authors: Djenaba A Joseph; Jacqueline W Miller; Xiaocheng Wu; Vivien W Chen; Cyllene R Morris; Marc T Goodman; Jose M Villalon-Gomez; Melanie A Williams; Rosemary D Cress Journal: Cancer Date: 2008-11-15 Impact factor: 6.860
Authors: Vivian Colón-López; Vilnery Rivera-Figueroa; Glizette O Arroyo-Morales; Diana T Medina-Laabes; Roxana Soto-Abreu; Manuel Rivera-Encarnación; Olga L Díaz-Miranda; Ana P Ortiz; Katelyn B Wells; Coralia Vázquez-Otero; Pamela C Hull Journal: BMC Public Health Date: 2021-07-01 Impact factor: 3.295
Authors: Jeslie M Ramos-Cartagena; Cynthia M Pérez; Humberto M Guiot; Claudia P Amaya-Ardilla; Maribel Tirado-Gómez; Ana P Ortiz Journal: J Low Genit Tract Dis Date: 2020-01 Impact factor: 3.842